Literature DB >> 8006583

Characterization of a cis-acting regulatory element which silences expression of the class II-A beta gene in epithelium.

S E Albert1, F Strutz, K Shelton, T Haverty, M J Sun, S R Li, A Denham, R A Maki, E G Neilson.   

Abstract

Class II major histocompatibility complex (MHC) genes encode for alpha/beta chain pairs that are constitutively expressed principally on mature B cells and dendritic cells in mice. These gene products are easily induced on macrophages with cytokines, and may also aberrantly appear on the surface of epithelium during immune injury. The appearance of class II determinants in parenchymal tissue potentially renders these somatic cells capable of antigen presentation to circulating CD4+ T lymphocytes, and their absence may be protective for normal tissues expressing self-antigens. The low surface class II expression observed on parenchymal cells generally correlates with low levels of mRNA, suggesting that transcription rate is a major element in class II regulation. To understand the transcriptional mechanism maintaining low basal surface expression of class II in somatic cells, we transiently transfected mini-gene reporter constructs to study the regulation of the murine A beta promoter in a cultured renal epithelial cell line. We describe here a negative cis-acting regulatory region located between -552 and -489 bp upstream of the A beta cap site that silences the transcriptional activity of the A beta promoter in epithelial cells in an orientation-dependent manner, and is also able to silence a heterologous promoter. This region is not active in class II-expressing B cells (BAL-17) in culture, but is functional in two other murine class II-negative cell lines, fibroblasts and thymoma T cells. Using competition electrophoretic mobility shift assays, we have localized the core protein binding site within this region to an 8-10-bp response element, designated A beta NRE, at -543 to -534 bp. A nuclear extract from BAL-17 cells does not bind to this element. Mutation of this site abrogates the transcriptional silencing activity of the region. We conclude that the transcription of class II-A beta in parenchymal cells, and some lymphocytes, can be actively repressed by an upstream silencing element.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006583      PMCID: PMC2191571          DOI: 10.1084/jem.180.1.233

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

Review 1.  T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.

Authors:  R H Schwartz
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

2.  Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts.

Authors:  J M Boss; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  Characterization of a "silencer" in yeast: a DNA sequence with properties opposite to those of a transcriptional enhancer.

Authors:  A H Brand; L Breeden; J Abraham; R Sternglanz; K Nasmyth
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

4.  Membrane IgM, IgD, and IgG act as signal transmission molecules in a series of B lymphomas.

Authors:  J Mizuguchi; W Tsang; S L Morrison; M A Beaven; W E Paul
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

5.  Functional subsets of B cells defined by quantitative differences in surface I-A.

Authors:  J L Greenstein; E M Lord; P Horan; J W Kappler; P Marrack
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

6.  Class II histocompatibility antigen-mediated immunologic function of normal articular chondrocytes.

Authors:  M L Tiku; S Liu; C W Weaver; M Teodorescu; J L Skosey
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

7.  Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells.

Authors:  M Londei; J R Lamb; G F Bottazzo; M Feldmann
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

8.  Repression of major histocompatibility complex IA expression by glucocorticoids: the glucocorticoid receptor inhibits the DNA binding of the X box DNA binding protein.

Authors:  A Celada; S McKercher; R A Maki
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

Review 9.  Organ-specific autoimmunity: a 1986 overview.

Authors:  G F Bottazzo; I Todd; R Mirakian; A Belfiore; R Pujol-Borrell
Journal:  Immunol Rev       Date:  1986-12       Impact factor: 12.988

10.  Membrane Ia expression and antigen-presenting accessory cell function of L cells transfected with class II major histocompatibility complex genes.

Authors:  M A Norcross; D M Bentley; D H Margulies; R N Germain
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Immunomodulation by interference with co-stimulatory molecules: therapeutic perspectives in asthma.

Authors:  S E Burastero; G A Rossi
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

2.  Repression of MHC class II gene transcription in trophoblast cells by novel single-stranded DNA binding proteins.

Authors:  S P Murphy; S O Gollnick; T Pazmany; P Maier; G Elkin; T B Tomasi
Journal:  Mol Reprod Dev       Date:  1997-08       Impact factor: 2.609

3.  Repression of major histocompatibility complex I-A beta gene expression by dbpA and dbpB (mYB-1) proteins.

Authors:  J Lloberas; R A Maki; A Celada
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

4.  Identification and characterization of a fibroblast marker: FSP1.

Authors:  F Strutz; H Okada; C W Lo; T Danoff; R L Carone; J E Tomaszewski; E G Neilson
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.